DrugPatentWatch Database Preview

Details for Patent: 7,473,761

« Back to Dashboard

Which drugs does patent 7,473,761 protect, and when does it expire?

Patent 7,473,761 protects SIGNIFOR LAR KIT and SIGNIFOR and is included in two NDAs.

This patent has forty-five patent family members in thirty-three countries.

Summary for Patent: 7,473,761

Title:	Somatostatin analogues
Abstract:	The invention provides cyclo[{4-(NH.sub.2--C.sub.2H.sub.4--NH--CO--O--)Pro}-Phg-DTrp-Lys-Tyr(4-B- enzyl)-Phe], optionally in protected form, or a pharmaceutically acceptable salt or complex thereof, which has interesting pharmaceutical properties.
Inventor(s):	Albert; Rainer (Basel, CH), Bauer; Wilfried (Lampenberg, CH), Bodmer; David (Klingnau, CH), Bruns; Christian (Freiburg, DE), Felner; Ivo (Reinach, CH), Hellstern; Heribert (Heitersheim, DE), Lewis; Ian (Riehen, CH), Meisenbach; Mark (Durmenach, FR), Weckbecker; Gisbert (Biel-Benken, CH), Wietfeld; Bernhard (Efringen-Kirchen, DE)
Assignee:	Novartis AG (Basel, CH)
Application Number:	10/343,288
Prior Art and Litigation Support	Order Prior Art and Litigation support for Patent 7,473,761
Patent Claim Types: see list of patent claims	Compound; Composition;

Drugs Protected by US Patent 7,473,761

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Novartis Pharms Corp	SIGNIFOR LAR KIT	pasireotide pamoate	FOR SUSPENSION;INTRAMUSCULAR	203255-001	Dec 15, 2014		RX	Yes	No			Y	Y
Novartis Pharms Corp	SIGNIFOR LAR KIT	pasireotide pamoate	FOR SUSPENSION;INTRAMUSCULAR	203255-002	Dec 15, 2014		RX	Yes	No			Y	Y
Novartis Pharms Corp	SIGNIFOR LAR KIT	pasireotide pamoate	FOR SUSPENSION;INTRAMUSCULAR	203255-003	Dec 15, 2014		RX	Yes	Yes			Y	Y
Novartis	SIGNIFOR	pasireotide diaspartate	SOLUTION;SUBCUTANEOUS	200677-001	Dec 14, 2012		RX	Yes	No			Y	Y
Novartis	SIGNIFOR	pasireotide diaspartate	SOLUTION;SUBCUTANEOUS	200677-002	Dec 14, 2012		RX	Yes	No			Y	Y
Novartis	SIGNIFOR	pasireotide diaspartate	SOLUTION;SUBCUTANEOUS	200677-003	Dec 14, 2012		RX	Yes	Yes			Y	Y

Foreign Priority and PCT Information for Patent: 7,473,761

PCT Information
PCT Filed	July 30, 2001	PCT Application Number:	PCT/EP01/08824
PCT Publication Date:	February 07, 2002	PCT Publication Number:	WO02/10192

International Family Members for US Patent 7,473,761

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	034132
Austria	393782
Australia	2001289778
Australia	8977801
Brazil	0112859
Brazil	PI0112859